FDA Hires Torti As First Chief Scientist
This article was originally published in The Pink Sheet Daily
Agency taps outsider to develop its fellowship program.
You may also be interested in...
Acting director made permanent at FDA's drug center.
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications
Interim data from SHARP and IMPROVE-IT trials fail to show evidence of impact on cancer rates.